SCHEMBL469486

SCHEMBL469486

Oc1c(/C=N/c2ccccc2)cccc1-c1c2ccccc2cc2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.46
POLB P06746 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
SIRT2 Q8IXJ6 2/20 0.45
MAPT P10636 4/20 0.44
RAB9A P51151 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
MAOB P27338 2/20 0.40
MAOA P21397 1/20 0.40
MEN1 O00255 4/20 0.40
GAA P10253 2/20 0.40
APAF1 O14727 1/20 0.40
ATM Q13315 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
THRB P10828 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14337245 0.84 POLB (0.52) KMT2APOLBL3MBTL1SIRT2MAPT
SCHEMBL10182675 0.82 ALDH1A1 (0.59) KMT2APOLBL3MBTL1MAPTRAB9A
SCHEMBL18525565 0.81 KMT2A (0.42) KMT2APOLBL3MBTL1MAPTRAB9A
SCHEMBL14337407 0.81 SIRT2 (0.55) KMT2ASIRT2MAPTRAB9ASMN1; SMN2
SCHEMBL10233787 0.80 L3MBTL1 (0.46) KMT2APOLBL3MBTL1MAPTRAB9A
SCHEMBL14276080 0.78 TSHR (0.43) KMT2APOLBL3MBTL1MAPTHPGD
SCHEMBL6155766 0.78 ERN1 (0.48) KMT2AMEN1THRBBLM
Hydrochloric Acid SCHEMBL30266729 0.78 SIRT2 (0.51) KMT2ASIRT2MAPTRAB9ASMN1; SMN2
SCHEMBL4574476 0.78 ERN1 (0.48) KMT2AMEN1THRBBLM
SCHEMBL14337279 0.77 KMT2A (0.47) KMT2APOLBL3MBTL1SIRT2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059993-A1 CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX SHOWA DENKO K.K. (JP) 2013-03-07 US disclosed
US-20130059993-A1 CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX SHOWA DENKO K.K. (JP) 2013-03-07 US disclosed
WO-2012033227-A2 CATALYST FOR POLYMERIZING NORBORNENE MONOMERS AND A METHOD FOR PRODUCING NORBORNENE POLYMER SHOWA DENKO K.K. (JP) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130059993-A1 CATALYST FOR POLYMERIZATION OF NORBORNENE MONOMERS, METHOD FOR PRODUCING NORBORNENE POLYMER, METHOD FOR PRODUCING NORBORNENE COPOLYMER, NORBORNENE POLYMER AND TRANSITION METAL COMPLEX NNMT, PPOX, DNMT1 KMT2A 1417/4885POLB 376/4885L3MBTL1 4555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.